STEPTRACKERIMMUNOLOGY + GENETICS | CELLS & ORGANS | HIGH-YIELD REVIEW

Lymphocyte Development & Selection

Lymphocytes build a random receptor by cutting and joining gene segments, then are tested — useless ones die, dangerous ones are deleted or silenced.

FOCUS ON
Receptor diversity: VDJ recombination by RAG1/RAG2 (+ Artemis, DNA repair) and junctional diversity (TdT adds N nucleotides); B cells add somatic hypermutation later. T cells (thymus): double-negative → double-positive (CD4⁺CD8⁺) in the cortex → positive selection (bind self-MHC weakly → survive; MHC I → CD8, MHC II → CD4) → negative selection in the medulla (bind self-antigen strongly → apoptosis; AIRE shows tissue antigens) → some become Tregs (FOXP3). B cells (marrow): pro-B → pre-B (μ heavy chain + surrogate light chain) → immature B (IgM) → mature naive B (IgM + IgD); self-reactive B cells undergo deletion, anergy or receptor editing. Defects: RAG → SCID (Omenn), AIRE → APS-1, FOXP3 → IPEX, BTK → XLA.
STEP
WHAT HAPPENS
MOLECULES
DEFECT → DISEASE
VDJ recombination
Gene segments for variable regions cut and joined; ~10¹¹ possible receptors
RAG1/RAG2 (recombinase), Artemis, DNA-PK
RAG/Artemis loss → SCID (T⁻B⁻NK⁺); partial → Omenn syndrome
Junctional diversity
Random nucleotides added at joints
TdT
TdT ⁺ marks lymphoblasts (ALL)
Allelic exclusion
Only one heavy- and one light-chain allele expressed per B cell
—
Each B cell makes one specificity
Pro-T → double-negative
Marrow progenitors enter thymus; CD4⁻CD8⁻
Notch, IL-7 (IL-7R, common γ chain, JAK3)
IL-7R / γc / JAK3 defects → SCID (T⁻B⁺NK⁻ for γc, JAK3)
Double-positive (cortex)
TCR rearranged; CD4⁺CD8⁺
—
—
Positive selection (cortex)
Thymocytes that bind self-MHC on cortical epithelial cells survive; most die by neglect
MHC I → CD8⁺ · MHC II → CD4⁺
Bare lymphocyte syndrome (no MHC II) → few CD4⁺ cells
Negative selection (medulla)
Strong binding to self-peptide on medullary cells/DCs → apoptosis
AIRE drives expression of tissue-specific antigens
AIRE loss → APS-1 (mucocutaneous candidiasis, hypoparathyroidism, Addison)
Regulatory T cells
Moderately self-reactive cells become Tregs
FOXP3, CD25, IL-2, IL-10, TGF-β
FOXP3 loss → IPEX (enteropathy, diabetes, eczema)
Pro-B → pre-B (marrow)
Heavy chain rearranged first; μ chain pairs with surrogate light chain (pre-BCR)
BTK signaling
BTK loss → XLA (no mature B cells)
Immature B cell
Light chain rearranged; surface IgM; self-reactive cells edited, deleted or made anergic
Receptor editing (new light chain)
Central B-cell tolerance
Mature naive B cell
IgM + IgD (alternative splicing); leaves marrow to follicles
CD19, CD20, CD21
Rituximab targets CD20
Peripheral tolerance
Anergy (signal 1 without B7–CD28), Tregs, deletion (Fas–FasL), immune privilege
CTLA-4, PD-1, Fas
Fas defect → autoimmune lymphoproliferative syndrome

Picture it — thymic selection

CORTEXMEDULLACD4⁺CD8⁺thymocyteno MHC bindingdeath by neglectweak self-MHC bindingPOSITIVE selectionMHC I → CD8 · MHC II → CD4lineage chosenstrong self-peptideNEGATIVE selection → apoptosismoderate self-bindingTreg (FOXP3)ignores selfmature naive T cell → bloodAIRE lets medullary cells display tissue-specific self antigens
Two tests in the thymusIn the cortex, thymocytes that cannot bind self-MHC die; weak binders survive and commit to CD4 or CD8. In the medulla, strong binders to self-peptide are deleted, moderate binders can become Tregs, and the rest leave as naive T cells.

Schematic diagrams, not to scale.

Mechanism — the two thymic tests

No binding to self-MHC
→
Death by neglectUseless
Weak binding
→
Positive selection → surviveCD4 or CD8 chosen
Strong binding to self-peptide
→
Negative selection → apoptosisor Treg

T vs B development

FEATURE
T CELL
B CELL
Site
Thymus
Bone marrow
Receptor
TCR (αβ or γδ)
BCR (surface Ig)
First chain
β chain + pre-Tα
μ heavy chain + surrogate light chain
Self-tolerance
Negative selection (AIRE), Tregs
Deletion, anergy, receptor editing
Later diversity
None
Somatic hypermutation, class switching

How it's tested

COMMON CONFUSIONPositive selection (cortex) tests MHC restriction; negative selection (medulla) tests self-reactivity — the location and the question differ.
THE TRAPAIRE deficiency causes autoimmunity, not immunodeficiency — but chronic Candida appears because of autoantibodies against IL-17/IL-22.
YOUR APPROACHDevelopmental step → gene needed → which cells are missing or self-reactive → resulting disease.

If you see… think…

Enzyme that cuts V, D, J segments → RAG1/RAG2
Enzyme adding random nucleotides, marker of lymphoblasts → TdT
Where positive selection happens → thymic cortex
Where negative selection happens → thymic medulla
Candidiasis + hypoparathyroidism + adrenal failure → AIRE deficiency (APS-1)
Infant boy with diarrhea, diabetes and eczema → IPEX (FOXP3)
Boy with no B cells and absent tonsils → BTK defect (XLA)
Mature naive B cell surface antibodies → IgM and IgD
Self-reactive B cell swaps its light chain → receptor editing
T-cell activation without B7–CD28 → anergy